SmallCap Explorer
- Home
- SmallCap Explorer
Latest Posts
-
Articles
-
Views
-
Author's Posts
The RBA’s benchmark interest rate remains unchanged at 4.35%
Calls from some quarters for the RBA to slip an interest rate cut into borrowers’ Christmas stockings have gone unheeded, with the Bank’s benchmark interest rate remaining at 4.35% following its December 2024 Board meeting. This closely-watched rate has now been set at 4.35% since December last year. What kept the RBA from changing the
Read MorePublic
AML3D Secures A$2.27M Contract with Tennessee Valley Authority to Expand US Presence
“This ARCEMY® X order from the TVA is very much aligned with the US Scale Up growth strategy we have in place,” said AML3D CEO Sean Ebert, as the company announced a landmark A$2.27 million contract to supply the Tennessee Valley Authority (TVA) with its large-scale ARCEMY® X system. The deal marks AML3D’s strategic expansion beyond
Read MorePublic
Australia’s GDP limps higher in September 2024 quarter
Australia’s economic growth, as measured by the ABS-compiled chain volume GDP statistics that adjust for price increases, rose by a paltry 0.3% in the September 2024 quarter, to be just 0.8% higher on an annual (through the year) basis. The markets were expected Australia’s quarterly economic growth increase to be around 0.5% in the latest
Read MorePublic
Invion doses first patient in phase I/II non-melanoma skin cancer trial
Invion (ASX:IVX) surged higher after announcing that it had completed the dosing of the first patient in its Phase I/II non-melanoma skin cancer (NMSC) trial conducted at Veracity Clinical Research (Veracity) in Brisbane. The trial marks a significant milestone for Invion and is designed to evaluate the safety and efficacy of its lead drug candidate
Read MorePublic
Wildcat delivers Australia’s largest undeveloped lithium resource
Mineral exploration business Wildcat Resources (ASX: WC8) has unveiled a significant resource estimate for its Tabba Tabba project in the Pilbara region of Western Australia, consisting of 74.1 million tonnes at a grade of 1.0 per cent lithium. According to the company, the project now holds Australia’s largest undeveloped publicly reported hard-rock lithium deposit. The
Read MorePublic
AML3D raise to fund doubling of US capacity and other growth initiatives
AML3D (ASX:AL3) announced the successful completion of a two-tranche institutional placement (“Placement”) to sophisticated investors, raising approximately $30 million. The Placement will see around 157.9 million new fully paid ordinary shares in AML3D issued at a price of $0.19 per share. The Placement was strongly supported by both existing AML3D shareholders and new institutional investors
Read MorePublic
Encounter Resources drill results confirm ‘high-grade’ niobium discovery
Encounter Resources (ASX:ENR) rose after announcing that the first reverse circulation (RC) drilling results from its Green prospect at the Aileron project in the West Arunta region of WA hosts extensive, enriched, high-grade niobium mineralisation in the upper portion of the system. Of the four initial RC holes completed in Green’s western area, three returned
Read MorePublic
Singular Health Group signs MOU and completes equity placement
Medical technology company Singular Health Group rose after it announced the signing of a Memorandum of Understanding (MOU) with Provider Network Solutions (PNS) to collaborate on a technical proof-of-concept and commercial pilot within the PNS Network. Singular Health also announced the completion of a successful equity placement of AUD3.7M at $0.09 per share, including an
Read MorePublic
Resonance soars on $14m contract win with big pharma
The share price of healthcare technology and services business Resonance Health (ASX: RHT) surged by more than 50 per cent on Tuesday after the company nailed down a two-year clinical trial agreement with Indian multinational pharmaceutical titan, Sun Pharmaceuticals. The $13.775 million deal will see Resonance act as the local Australian sponsor and provide clinical
Read MorePublic
Petratherm surges on ‘outstanding’ Rosewood metallurgical results
Petratherm (ASX:PTR) rallied strongly after announcing results from an initial trial heavy mineral sand (HMS) separation test using samples collected from historic drill holes stored at the South Australian Core Library (CAR series drill holes). The composite samples were collected from widely spaced contiguous drill holes along a 2.5-kilometre-long traverse on the eastern side of
Read MorePublic
Spectur nails down long-term government contract as sales gather momentum
Spectur (ASX: SP3), a specialist in smart security systems powered by solar technology, has locked in a three-year agreement valued at close to $800,000 for the provision of its cameras and analytic services to government agency Transport for New South Wales. The contract also allows for a potential site expansion which could help boost the
Read MorePublic
Aussie mining heads to paradise for showpiece industry event
The Australian mining industry flocked to tropical Queensland this week for one of the most distinguished events on the calendar for ASX-listed producers, explorers, and resource developers: the Noosa Mining Investor Conference hosted by Brisbane-based outfit, Equity Events. Held twice a year at the Peppers Noosa Resort on the top end of Queensland’s pristine Sunshine
Read MorePublic
Biome leaps into Canada as sales in Australia skyrocket
Biome Australia (ASX: BIO), a healthcare business specialising in developing, marketing, and distributing probiotic and complementary health products, has spread its wings into the Canadian market after generating positive feedback and encouraging early sales during a two-month testing period. Management believes the Canadian market is now adequately derisked for the company to march forward with
Read MorePublic
EMVision takes key step in advancing stroke diagnosis technology
Medical device company EMVision (ASX: EMV) has reported “excellent” results from a study gauging the effectiveness of its cutting-edge neurodiagnostic technology for the identification of stroke and stroke types. The multi-site study – known as EMView – involved the testing of diagnostic algorithms on unseen data from 307 participants across the Liverpool, Royal Melbourne, and
Read MorePublic
Novonix nails down graphite supply deal with global automotive giant
Battery technology business Novonix (ASX: NVX) has entered a binding offtake agreement to supply its high-performance synthetic graphite material to the battery cell manufacturing partners of multinational automotive titan, Stellantis. Commencing in 2026, the six-year deal will see Novonix deliver a minimum of 86,250 tonnes of graphite and up to 115,000 tonnes of the material
Read MorePublic
Equinox Resources says rock chip samples from Alturas return ‘ultra-high grade antimony assays’
Equinox Resources (ASX: EQN) rallied after announcing that reconnaissance assay results from the maiden exploration program at its Alturas antimony project in British Columbia, Canada had returned ultra-high grade naturally occurring antimony, with assays up to 69.98% antimony. Equinox Resources also announced an expansion of its Alturas project, with the Company pegging two additional claims
Read MorePublic
Quickstep jumps post contracts update and takeover offer
Quickstep Holdings (ASX:QHL) has had a busy day, announcing (1) the successful finalisation of key negotiations with its Tier 1 defence customers, incorporating terms that reflect mutually acceptable volumes and pricing adjustments and (2) a takeover offer from ASDAM Operations Pty Limited. Contracts update C-130 Program with Lockheed Martin: Quickstep Holdings secures volume and increased
Read MorePublic
Progresses Benchmarking for EMASS Semiconductor Technology
Second Benchmark testing for the ECS-DOT chipset by Embedded A.I Systems Pte. Ltd (EMASS) is scheduled to commence on 7 November, 2024, with results expected within a week The tests will focus on two critical applications, Anomaly Detection and Keyword Spotting, using standardised workloads from the MLPerf Tiny AI suite The EMASS ECS-DOT’s chipset performance
Read MorePublic
RBA keeps benchmark interest rate at 4.35%
Those calling for the RBA to cut its benchmark interest rate on Melbourne Cup have backed the wrong horse – all they got was a hoarse voice! The RBA statement accompanying the Bank’s 5 November 2024 rates decision clearly stated the obstacles to any near term rate cut – and reiterated its ‘highest priority’, which
Read MorePublic
Issues clinical trial update of its Phase 1 MAST trial
Clinical stage immuno-oncology company Imugene Limited (ASX:IMU) provided a clinical trial update of its Phase 1 MAST (Metastatic Advanced Solid Tumours) trial evaluating the safety and efficacy of novel cancer-killing virus CF33-hNIS (VAXINIA). Patient hits major milestone in CF33 MAST VAXINIA study, with ‘complete response’ for over two years The Cohort review committee has cleared
Read MorePublic
Drilling intersects Shallow, High-Grade Gold Mineralisation at Barimaia Gold Project
Ordell Minerals (ASX:ORD) has reported ‘significant drill results’ from its recent shallow, wide-spaced Reverse Circulation (RC) drilling program at the Company’s Barimaia Gold Project, located near Mount Magnet in the WA-based Murchison region. These RC drilling activities, completed in September and October 2024, represented the second phase of Ordell Minerals’ larger, ongoing program to systematically
Read MorePublic
Mineral Resources inks $1.1 billion gas deal with Gina Rinehart
Diversified mining business Mineral Resources (ASX:MIN) has struck a deal with Gina Rinehart’s Hancock Prospecting for the sale of two of its oil and gas exploration permits in the Perth Basin of Western Australia. In addition, the duo has entered joint venture (JV) agreements over Mineral Resources’ remaining exploration ground in the Perth Basin and
Read MorePublic
OD6 Metals soars on the back of rich NSW copper acquisition
Shares in mineral exploration business OD6 Metals (ASX: OD6) rocketed by 75 per cent on Wednesday after the group reported its proposed acquisition of one of Australia’s highest grade historical copper mines, known as the Gulf Creek project. Located near the town of Burra in New South Wales, Gulf Creek is a volcanogenic massive sulphide
Read MorePublic
Zip Co jumps as growth in core US market gathers momentum
Digital financial services business Zip Co (ASX: ZIP) saw its share price jump by 12 per cent on Tuesday after delivering a strong set of numbers for the first quarter of FY25. Notably, group cash operating earnings (EBITDA) of $31.7 million soared by 234 per cent from the same time last year as the company
Read MorePublic
Telix takes key step in US commercialisation push for brain cancer imaging agent
Commercial-stage biopharmaceutical business Telix Pharmaceuticals (ASX: TLX) has moved a step closer to bringing to market its brain tumour imaging product known as Pixclara, after receiving ‘New Drug Application’ (NDA) status from the US Food and Drug Administration (FDA). The company’s formal application has now been granted priority review by the FDA, with a commercial
Read MorePublic
Adisyn set for data centre market boost with proposed acquisition of 2D Generation
Technology services and solutions business Adisyn (ASX: AI1) appears set to broaden its exposure to the burgeoning semiconductor sector through a proposed acquisition of innovative high-tech company, 2D Generation. The deal could see Adisyn boost its penetration into target markets such as data centres, cybersecurity, and the defense industry. The tabled acquisition builds on
Read MorePublic
Yandal shines as new WA gold discovery begins to take shape
Mineral exploration business Yandall Resources (ASX: YRL) saw its share price double on Monday after the group delivered an “exceptional” gold hit from drilling at its New England Granite prospect, located within the company’s broader tenure at its flagship Well-Barwidgee gold project in Western Australia. The wide 78 metre intercept grading 1.2 grams per tonne
Read MorePublic
Nyrada soars as stroke and brain injury drug approaches clinical trial
Shares in biotechnology business Nyrada (ASX: NYR) lifted by nearly 40 per cent on Wednesday following the successful completion of safety studies on its lead drug candidate for the treatment of traumatic brain injury and strokes, NYR-BI03. The favourable results have now opened the door for a first clinical trial of the drug on humans
Read MorePublic
AnteoTech scores maiden commercial order from European EV maker for its innovative silicon battery technology
Clean energy and high-tech materials company AnteoTech (ASX: ADO) has received a first commercial order for its proprietary Ultranode battery anode technology which contains 70 per cent silicon. The initial $40,000 purchase will see an unnamed “major” European electric vehicle (EV) manufacturer – known as EV1 – test and evaluate the technology over the coming
Read MorePublic
African Gold soars on the back of spectacular gold hits in Côte d’Ivoire
Shares in mineral exploration business African Gold (ASX: A1G) more than doubled on Tuesday after the company delivered “spectacular” gold intercepts from drilling at its Didievi project in the West African nation of Côte d’Ivoire. The new results from one diamond drill hole at the Blaffo Guetto prospect were headlined by a broad and high-grade
Read MorePublic
James Bay Minerals (ASX:JBY): Transformational acquisition of US-based high-grade Gold Project
James Bay Minerals (ASX: JBY) (‘James Bay’) has entered a binding agreement that gives the Company the right to acquire up to 100% of the advanced Independence Gold Project, located in Nevada, United States of America. The Independence Project is presently owned by Independence Mining LLC, an incorporated joint venture between Battle Mountain Resources Pty
Read MorePublic
Rio Tinto shines light on lithium sector with US$6.7 billion acquisition of Arcadium
Diversified mining titan Rio Tinto (ASX: RIO) is set to purchase the “world-class” lithium chemical producer Arcadium Lithium in an effort to grow its position as a global leader in the production of energy transition commodities. Valued at US$6.7 billion, the all-cash deal represents a sturdy 90 per cent premium to Arcadium’s closing share price
Read MorePublic
Echo IQ appoints healthcare guru to drive US commercialisation of its diagnostic heart disease platform after securing regulatory clearance
Medical technology company Echo IQ (ASX:EIQ) has employed leading American healthcare executive, Dustin Haines, as new chief executive officer (CEO) to spearhead efforts to commercialise and scale its EchoSolv artificial intelligence powered platform in the lucrative US market. The innovative platform is designed to automatically identify patients at risk of structural heart disease with unparalleled
Read MorePublic
Orthocell locks in Singaporean regulatory approval in international commercialisation push for nerve repair product
Regenerative medicine business Orthocell (ASX: OCC) has nailed down its first international regulatory approval for the group’s nerve repair product known as Remplir. The formal authorisation from the Health Sciences Authority in Singapore allows the company to begin sales in the nation and builds on its existing markets for the product in Australia and New
Read MorePublic
